Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 30 (EEF1A1P30)
- Target
- EEF1A1P30
- Molecular classification
- Other (Pseudogene, specifically a processed or unprocessed pseudogene)
01
Overview
EEF1A1P30 is a human pseudogene related to the protein-coding gene eukaryotic translation elongation factor 1 alpha 1 (EEF1A1). Pseudogenes like EEF1A1P30 arise from duplication or retrotransposition of functional genes but have lost protein-coding capability due to disabling mutations or loss of regulatory elements. They are generally transcriptionally inactive, although some pseudogenes in this gene family have regulatory RNA roles, but no evidence currently exists for a specific biological function for EEF1A1P30. EEF1A1P30 is not a protein, enzyme, receptor, or recognized therapeutic target, and has no known drug interactions, biomarker utility, or disease association.
02
Mechanism of action
None. There are no drugs targeting EEF1A1P30, so no mechanism of action applies
03
Biological functions
Other (pseudogenes do not code for proteins; some may have regulatory roles but these are undocumented for EEF1A1P30 specifically)
04
Disease associations
Other (There is no evidence for disease association, biomarker status, or involvement in any pathology for EEF1A1P30 specifically; research cited is for the family or for protein-coding parent gene, not for this pseudogene)
Beyond the preview
Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 30 (EEF1A1P30).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 30 (EEF1A1P30).